CIDARA THERAPEUTICS, INC. Operating Cash Flow
CIDARA THERAPEUTICS, INC. reported Operating Cash Flow of -$103.53 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-11-06
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$40.62M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$40.96M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$21.95M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$29.41M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$176.53M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$22.43M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$28.47M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$25.23M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$40.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$81.58M derived: sum of 2 quarters · filed 2025-11-06 | -$103.53M 10-Q · filed 2025-11-06 | -$132.94M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | -$40.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$62.91M 10-Q · filed 2025-08-07 | -$92.33M derived: sum of 3 quarters · filed 2025-08-07 | -$129.02M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | -$21.95M 10-Q · filed 2025-05-08 | -$51.36M derived: sum of 2 quarters · filed 2025-05-08 | -$88.06M derived: sum of 3 quarters · filed 2025-11-06 | -$191.84M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | -$29.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$66.11M derived: sum of 2 quarters · filed 2025-11-06 | -$169.89M derived: sum of 3 quarters · filed 2025-11-06 | -$176.53M 10-K · filed 2025-03-06 |
| 2024-09-30 | -$36.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$140.47M derived: sum of 2 quarters · filed 2025-11-06 | -$147.12M 10-Q · filed 2025-11-06 | -$159.84M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$103.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$110.42M 10-Q · filed 2025-08-07 | -$123.15M derived: sum of 3 quarters · filed 2025-08-07 | -$124.78M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$6.64M 10-Q · filed 2025-05-08 | -$19.37M derived: sum of 2 quarters · filed 2025-05-08 | -$21.00M derived: sum of 3 quarters · filed 2025-05-08 | -$18.18M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$12.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$14.36M derived: sum of 2 quarters · filed 2025-03-06 | -$11.53M derived: sum of 3 quarters · filed 2025-03-06 | -$22.43M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.19M derived: sum of 2 quarters · filed 2024-11-07 | -$9.71M 10-Q · filed 2024-11-07 | -$30.71M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $2.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$8.08M 10-Q · filed 2024-08-13 | -$29.08M derived: sum of 3 quarters · filed 2024-08-13 | -$1.10M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$10.90M 10-Q · filed 2024-05-15 | -$31.90M derived: sum of 2 quarters · filed 2024-05-15 | -$3.93M derived: sum of 3 quarters · filed 2024-05-15 | -$15.76M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$21.00M derived: 10-K 12 month − 10-K 9 month · filed 2024-04-22 | $6.97M derived: sum of 2 quarters · filed 2024-04-22 | -$4.87M derived: sum of 3 quarters · filed 2024-04-22 | -$28.47M 10-K · filed 2024-04-22 |
| 2022-09-30 | $27.97M derived: 10-K 9 month − 10-K 6 month · filed 2024-04-22 | $16.14M derived: sum of 2 quarters · filed 2024-04-22 | -$7.47M 10-K · filed 2024-04-22 | -$22.38M derived: sum of 4 quarters · filed 2024-04-22 |
| 2022-06-30 | -$11.84M derived: 10-K 6 month − 10-K 3 month · filed 2024-04-22 | -$35.44M 10-K · filed 2024-04-22 | -$50.35M derived: sum of 3 quarters · filed 2024-04-22 | -$62.32M derived: sum of 4 quarters · filed 2024-04-22 |
| 2022-03-31 | -$23.61M 10-K · filed 2024-04-22 | -$38.52M derived: sum of 2 quarters · filed 2024-04-22 | -$50.49M derived: sum of 3 quarters · filed 2024-04-22 | -$47.05M derived: sum of 4 quarters · filed 2024-04-22 |
| 2021-12-31 | -$14.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$26.88M derived: sum of 2 quarters · filed 2023-03-23 | -$23.44M derived: sum of 3 quarters · filed 2023-03-23 | -$25.23M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$11.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$8.53M derived: sum of 2 quarters · filed 2022-11-03 | -$10.32M 10-Q · filed 2022-11-03 | -$21.45M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.65M 10-Q · filed 2022-08-09 | -$9.48M derived: sum of 3 quarters · filed 2023-03-23 | -$23.56M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | -$1.79M 10-Q · filed 2022-05-11 | -$12.92M derived: sum of 2 quarters · filed 2023-03-23 | -$27.00M derived: sum of 3 quarters · filed 2023-03-23 | -$41.08M derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | -$11.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$25.21M derived: sum of 2 quarters · filed 2023-03-23 | -$39.28M derived: sum of 3 quarters · filed 2023-03-23 | -$54.41M 10-K · filed 2023-03-23 |
| 2020-09-30 | -$14.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$28.16M derived: sum of 2 quarters · filed 2021-11-10 | -$43.28M 10-Q · filed 2021-11-10 | -$58.48M derived: sum of 4 quarters · filed 2022-03-07 |
| 2020-06-30 | -$14.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$29.20M 10-Q · filed 2021-08-12 | -$44.40M derived: sum of 3 quarters · filed 2022-03-07 | -$27.78M derived: sum of 4 quarters · filed 2022-03-07 |
| 2020-03-31 | -$15.13M 10-Q · filed 2021-05-13 | -$30.32M derived: sum of 2 quarters · filed 2022-03-07 | -$13.71M derived: sum of 3 quarters · filed 2022-03-07 | -$26.51M derived: sum of 4 quarters · filed 2022-03-07 |
| 2019-12-31 | -$15.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $1.42M derived: sum of 2 quarters · filed 2022-03-07 | -$11.39M derived: sum of 3 quarters · filed 2022-03-07 | -$28.53M 10-K · filed 2022-03-07 |
| 2019-09-30 | $16.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.81M derived: sum of 2 quarters · filed 2020-11-05 | -$13.34M 10-Q · filed 2020-11-05 | -$27.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$12.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$29.95M 10-Q · filed 2020-08-13 | -$43.62M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2019-03-31 | -$17.15M 10-Q · filed 2020-05-13 | -$30.81M derived: sum of 2 quarters · filed 2021-02-25 | ||
| 2018-12-31 | -$13.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$56.70M 10-K · filed 2021-02-25 | ||
| 2018-09-30 | -$43.04M 10-Q · filed 2019-11-08 | |||
| 2017-12-31 | -$9.49M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | -$49.91M 10-K · filed 2020-03-04 | ||
| 2017-09-30 | -$40.42M 10-Q · filed 2018-11-08 | |||
| 2016-12-31 | -$39.77M 10-K · filed 2019-02-28 |